SCHEMBL7984872

SCHEMBL7984872

Nc1nc(OCC2C=CCCC2)c2nc[nH]c2n1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CDK2 P24941 14/20 0.42
CCNA2 P20248 12/20 0.42
CDK1 P06493 10/20 0.42
CCNB1 P14635 10/20 0.42
CCNA1 P78396 10/20 0.42
CCNB2 O95067 3/20 0.41
CCNB3 Q8WWL7 3/20 0.41
MAPK3 P27361 1/20 0.41
CLK1 P49759 1/20 0.41
CDK5 Q00535 1/20 0.41
PIN1 Q13526 1/20 0.41
MAP3K5 Q99683 1/20 0.41
MGMT P16455 3/20 0.33
MEN1 O00255 2/20 0.30
KMT2A Q03164 2/20 0.30
MTOR P42345 1/20 0.30
ATR Q13535 1/20 0.30
ALDH1A1 P00352 1/20 0.30
TSHR P16473 1/20 0.30
SMN1; SMN2 Q16637 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7984874 0.81 CDK1 (0.66) CDK2CCNA2CDK1CCNB1CCNA1
SCHEMBL6266040 0.80 CDK2 (0.64) CDK2CCNA2CDK1CCNB1CCNA1
SCHEMBL8826249 0.79 CDK2 (0.56) CDK2CCNA2CDK1CCNB1CCNA1
SCHEMBL29385503 0.79 CDK2 (0.64) CDK2CCNA2CDK1CCNB1CCNA1
SCHEMBL4402025 0.79 CDK2 (0.64) CDK2CCNA2CDK1CCNB1CCNA1
SCHEMBL6267556 0.77 CDK2 (0.67) CDK2CCNA2CDK1CCNB1CCNA1
SCHEMBL8830357 0.77 CDK2 (0.40) CDK2CCNA2CDK1CCNB1CCNA1
SCHEMBL21484455 0.72 CDK2 (0.36) CDK2CCNA2CDK1CCNB1CCNA1
SCHEMBL30583141 0.71 IRAK4 (0.41) CDK2CCNA2CDK1CCNB1CCNA1
SCHEMBL4556489 0.71 IRAK4 (0.41) CDK2CCNA2CDK1CCNB1CCNA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6303618-B1 ADMINISTERING PURINE COMPOUND WHICH INHIBITS CYCLIC DEPENDENT KINASE ACTIVITY FOR THERAPY OF TUMOR OR OTHER CELL PROLIFERATION DISORDER CANCER RESEARCH CAMPAIGN TECHNOLOGY LIMITED (GB) 2001-10-16 US disclosed